WilmerHale Reps Eko Devices in $5M Series A Round Led by ARTIS Ventures

Download IconDownload Print IconPrint

WilmerHale Reps Eko Devices in $5M Series A Round Led by ARTIS Ventures

Firm News

Related Solutions

Helping clients launch their businesses and transform their innovative ideas into successful companies.
Advising life sciences innovators, investors and industry leaders on complex transactions, legal issues and business challenges.

On February 28, 2018, Eko Devices, a leader in acoustic cardiac monitoring, announced that it closed $5 million in Series A funding to grow its commercial team and to expand clinical studies on the use of its platform for valvular heart disease screening and heart failure monitoring. ARTIS Ventures led the round, with additional participation from Strategic Partners, DreamIt Ventures, 1812 Ventures, and FOUNDER.org.

WilmerHale's Joe Wyatt and Molly Holsinger represented Eko Devices in this transaction.

View Eko's full release about this announcement.

Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.

I Accept Cancel